Transgenic Animal Market to be dominated by Growing Consumption of Animal-derived Protein and Dairy Products through 2027

Growing consumption of animal-derived protein and rise in R&D activities to drive the transgenic animal market in the forecast period, 2023-2027.

According to TechSci Research report, “Transgenic Animal Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027”, the global transgenic animal market is anticipated to grow at a significant rate in the forecast period, 2023-2027. The increase in consumption of animal-derived protein and dairy products and rise in R&D activities are the primary factors driving the demand for the global transgenic animal market. Growing technological advancement, wide application in various areas, and heavy investments in R&D activities are expected to influence the market demand. Also, the rise in population and rapid urbanization worldwide are also a key factor for driving the growth of the transgenic animal market, globally.

However Strict rules of government and the policies so put forward by the FDA act as a restraining factor affecting transgenic animals market growth.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Transgenic Animal Market"

The global transgenic animal market is segmented product, PCR, technique, application, model organism, end user and company.

Based on product, the market is divided into gene gun, PCR, microinjections, and others. The PCR segment is sub-segmented into real-time PCR, digital PCR systems, and others. The PCR segment is expected to hold the largest market share as it is the most effective method for detecting minor degenerated nucleic acids and determining their sequence. Also, it only uses a DNA fragment to detect species.

Based on technique, the market is segmented into DNA microinjection, embryonic stem cell-mediated gene transfer, retrovirus-mediated gene transfer, and others.  The DNA microinjection is forecasted to hold the largest market share, owing to the potential applications of these techniques in the correction of genetic defects, its simplicity and efficiency.

Based on application, the market is segmented into recombinant human proteins, monoclonal antibodies, xenotransplantation, and others. The monoclonal antibodies are predicted to hold a significant market share as they aims to enhance or provoke one's immune system to produce antibodies that are efficacious in fighting the foreign antigen.

Based on model organisms, the market is segmented into mice, rabbit, cow, and others. The mice segment is projected to grow the market in upcoming years, owing to their genetic similarity to humans, and increasing use in the study of human diseases.

Based on end user, the market is segmented into biotechnology & pharmaceutical companies, academic & research organizations, and others. The academic & research organizations are augmenting the market growth due to the increasing demand for the development of novel drugs and specialized medications, and growing R&D & clinical trials across the globe.

Major operating companies operating in global Transgenic Animal market are:

·         Market Players Merck & Co., Inc.

·         C.H. Boehringer Sohn Ko. KG

·         Randox Laboratories Limited, Zoetis, Inc.

·         Virbac SA, Elanco Animal Health Inc.

·         Biogénesis Bagó SA

·         Santa Cruz Biotechnology, Inc

·         Idexx Laboratories, Inc.

·         Innovative Diagnostics (IDVet)

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“Asia-Pacific region dominates the market in 2021 and is expected to maintain its dominance in the coming years due to increase in R&D initiatives and enhanced investments from governments for overall R&D of drugs. Also, availability of advanced healthcare systems, and increase in population contribute to propel the global transgenic animal market growth till 2027” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Transgenic Animal Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product (Gene Gun, PCR, Microinjections, Others), By PCR (Real-Time PCR, Digital PCR Systems, Others), By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others), By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others), By Model Organisms (Mice, Rabbit, Cow, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others), By Company, and By Region”, has evaluated the future growth potential of transgenic animal and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global transgenic animal market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com